Fmr LLC Lucid Diagnostics Inc. Transaction History

Fmr LLC

$1.49 Trillion
Q1 2025

A detailed history of Fmr LLC transactions in Lucid Diagnostics Inc. stock. As of the latest transaction made, Fmr LLC holds 555 shares of LUCD stock, worth $710. This represents 0.0% of its overall portfolio holdings.

Number of Shares

555

Holding current value

$710

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 May 12, 2025	BUY	$0.79 - $1.59 $438 - $882	555 New	555 $0
Q2 2022 Aug 12, 2022	BUY	$1.73 - $3.44 $314 - $626	182 New	182 $0

Others Institutions Holding LUCD

# of Institutions

Shares Held

9.45M

Call Options Held

Put Options Held

Masters Capital Management LLC Atlanta, GA

2.73M
Shares

$3.49 Million
0.21% of portfolio
Alyeska Investment Group, L.P. Chicago, IL

1.89M
Shares

$2.42 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

889K
Shares

$1.14 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

459K
Shares

$587,603
0.0% of portfolio
Luminus Management LLC Houston, TX

457K
Shares

$584,504
0.62% of portfolio

View Full List

About Lucid Diagnostics Inc.

Ticker LUCD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 38,568,500
Market Cap $49.4M
Description
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarc...

More about LUCD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account